Búsqueda | Portal de Búsqueda de la BVS Ecuador

1.

Determination of a Serum 25-Hydroxyvitamin D Reference Ranges in Japanese Adults Using Fully Automated Liquid Chromatography-Tandem Mass Spectrometry.

Miyamoto, Hiroyasu; Kawakami, Daisuke; Hanafusa, Nobuhiro; Nakanishi, Tsuyoshi; Miyasaka, Masaki; Furutani, Yutaka; Ikeda, Yuichi; Ito, Kyoko; Kato, Tomohiro; Yokoyama, Keitaro; Arakawa, Shoutaro; Saito, Mitsuru; Furusho, Tadasu; Matsuura, Tomokazu; Ochi, Sae.

J Nutr ; 153(4): 1253-1264, 2023 04.

Artículo en Inglés | MEDLINE | ID: mdl-36806449

2.

Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study.

Yokoyama, Keitaro; Hashimoto, Teruo; Okuda, Yuri; Matsumoto, Yu; Ito, Kyoko; Yamada, Ryoichi; Susai, Hiroyuki; Nishino, Noriaki.

Clin Exp Nephrol ; 26(7): 688-699, 2022 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-35258721

3.

Safety and efficacy of etelcalcetide, an intravenous calcimimetic, for up to 52 weeks in hemodialysis patients with secondary hyperparathyroidism: results of a post-marketing surveillance in Japan.

Yokoyama, Keitaro; Fukagawa, Masafumi; Shigematsu, Takashi; Akiba, Takashi; Yoshikawa, Ken; Tsuchiya, Akira; Kuwabara, Misato; Akizawa, Tadao.

Clin Exp Nephrol ; 25(1): 66-79, 2021 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-32816132

4.

Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study.

Ito, Kyoko; Yokoyama, Keitaro; Nakayama, Masaaki; Fukagawa, Masafumi; Hirakata, Hideki.

BMC Nephrol ; 22(1): 374, 2021 11 10.

Artículo en Inglés | MEDLINE | ID: mdl-34758731

5.

Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study.

Asada, Shinji; Yokoyama, Keitaro; Miyakoshi, Chisato; Fukuma, Shingo; Endo, Yuichi; Wada, Michihito; Nomura, Takanobu; Onishi, Yoshihiro; Fukagawa, Masafumi; Fukuhara, Shunichi; Akizawa, Tadao.

Clin Exp Nephrol ; 24(7): 630-637, 2020 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-32236781

6.

Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism.

Shigematsu, Takashi; Fukagawa, Masafumi; Yokoyama, Keitaro; Akiba, Takashi; Fujii, Akifumi; Shinoda, Atsushi; Akizawa, Tadao.

Nephrology (Carlton) ; 25(8): 634-643, 2020 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-31765028

7.

Clinical outcome of incident peritoneal dialysis patients with diabetic kidney disease.

Kishida, Kyoko; Maruyama, Yukio; Asari, Kana; Nakao, Masatsugu; Matsuo, Nanae; Tanno, Yudo; Ohkido, Ichiro; Ikeda, Masato; Yokoyama, Keitaro; Yokoo, Takashi.

Clin Exp Nephrol ; 23(3): 409-414, 2019 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-30255261

8.

Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism.

Shigematsu, Takashi; Fukagawa, Masafumi; Yokoyama, Keitaro; Akiba, Takashi; Fujii, Akifumi; Odani, Motoi; Akizawa, Tadao.

Clin Exp Nephrol ; 22(2): 426-436, 2018 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-28836058

9.

Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy.

Yokoyama, Keitaro; Kurita, Noriaki; Fukuma, Shingo; Akizawa, Tadao; Fukagawa, Masafumi; Onishi, Yoshihiro; Kurokawa, Kiyoshi; Fukuhara, Shunichi.

Nephrol Dial Transplant ; 32(3): 534-541, 2017 03 01.

Artículo en Inglés | MEDLINE | ID: mdl-26945054

10.

A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients.

Fukagawa, Masafumi; Yokoyama, Keitaro; Shigematsu, Takashi; Akiba, Takashi; Fujii, Akifumi; Kuramoto, Takuto; Odani, Motoi; Akizawa, Tadao.

Nephrol Dial Transplant ; 32(10): 1723-1730, 2017 Oct 01.

Artículo en Inglés | MEDLINE | ID: mdl-28057872

11.

A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patientsâ©.

Yokoyama, Keitaro; Fukagawa, Masafumi; Shigematsu, Takashi; Akiba, Takashi; Fujii, Akifumi; Odani, Motoi; Akizawa, Tadao.

Clin Nephrol ; 88(2): 68-78, 2017 08.

Artículo en Inglés | MEDLINE | ID: mdl-28671062

12.

Management of phosphorus load in CKD patients.

Taketani, Yutaka; Koiwa, Fumihiko; Yokoyama, Keitaro.

Clin Exp Nephrol ; 21(Suppl 1): 27-36, 2017 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-27896453

13.

Recurrence and graft loss after renal transplantation in adults with IgA vasculitis.

Kawabe, Mayuko; Yamamoto, Izumi; Komatsuzaki, Yo; Yamakawa, Takafumi; Katsumata, Haruki; Katsuma, Ai; Mafune, Aki; Nakada, Yasuyuki; Kobayashi, Akimitsu; Tanno, Yudo; Ohkido, Ichiro; Tsuboi, Nobuo; Yokoyama, Keitaro; Horita, Shigeru; Okumi, Masayoshi; Ishida, Hideki; Yamamoto, Hiroyasu; Yokoo, Takashi; Tanabe, Kazunari.

Clin Exp Nephrol ; 21(4): 714-720, 2017 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-27677884

14.

Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney disease.

Ikeda, Masato; Ueda, Yoshimi; Maruyama, Yukio; Yokoyama, Keitaro; Yokoo, Takashi; Joki, Nobuhiko; Ando, Ryoichi; Shinoda, Toshio; Inaguma, Daijo; Yamaka, Toshihiko; Komatsu, Yasuhiro; Koiwa, Fumihiko; Sakaguchi, Toshifumi; Negi, Shigeo; Shigematsu, Takashi.

Clin Exp Nephrol ; 21(5): 825-834, 2017 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-27844184

15.

Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.

Koiwa, Fumihiko; Yokoyama, Keitaro; Fukagawa, Masafumi; Terao, Akira; Akizawa, Tadao.

Nephrology (Carlton) ; 22(4): 293-300, 2017 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-27496336

16.

Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36-year experience in a University Hospital.

Nakao, Masatsugu; Yamamoto, Izumi; Maruyama, Yukio; Morishita, Masamitsu; Nakashima, Akio; Matsuo, Nanae; Tanno, Yudo; Ohkido, Ichiro; Ikeda, Masato; Yamamoto, Hiroyasu; Yokoyama, Keitaro; Yokoo, Takashi.

Nephrology (Carlton) ; 22(11): 907-912, 2017 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-27556577

17.

Long-Term Assessment of the Safety and Efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese Hemodialysis Patients With Hyperphosphatemia: An Open-Label, Multicenter, Phase III Study.

Koiwa, Fumihiko; Yokoyama, Keitaro; Fukagawa, Masafumi; Akizawa, Tadao.

J Ren Nutr ; 27(5): 346-354, 2017 09.

Artículo en Inglés | MEDLINE | ID: mdl-28550969

18.

The differences in acid-base status and the calcium parathyroid axis between peritoneal dialysis and hemodialysis.

Morishita, Masamitsu; Matsuo, Nanae; Maruyama, Yukio; Nakao, Masatsugu; Yamamoto, Izumi; Tanno, Yudo; Ohkido, Ichiro; Ikeda, Masato; Yokoyama, Keitaro; Yokoo, Takashi.

Clin Nephrol ; 86(2): 55-61, 2016 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-27345183

19.

Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.

Mafune, Aki; Iwamoto, Takeo; Tsutsumi, Yusuke; Nakashima, Akio; Yamamoto, Izumi; Yokoyama, Keitaro; Yokoo, Takashi; Urashima, Mitsuyoshi.

Clin Exp Nephrol ; 20(5): 731-739, 2016 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-26676906

20.

[Phosphate metabolism and iron deficiency].

Yokoyama, Keitaro.

Clin Calcium ; 26(2): 241-9, 2016 Feb.

Artículo en Japonés | MEDLINE | ID: mdl-26813504

Portal de Búsqueda de la BVS Ecuador

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: